Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$10.22
-0.4%
$8.70
$6.85
$10.79
$517.51M1.61455,843 shs209,368 shs
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$20.31
-1.0%
$18.41
$14.57
$25.11
$618.32M1278,630 shs213,204 shs
InnovAge Holding Corp. stock logo
INNV
InnovAge
$3.93
-2.2%
$3.20
$2.60
$6.69
$530.60M0.452,577 shs20,525 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$3.02
+1.0%
$2.12
$0.13
$3.50
$228.19M0.04924,357 shs2.10 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
0.00%-4.03%+32.76%+25.58%+8.45%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
0.00%-0.20%+6.67%+23.39%-4.87%
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.00%-6.21%+25.56%+18.37%-13.63%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
0.00%+1.00%-6.50%+239.36%+429.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Enhabit, Inc. stock logo
EHAB
Enhabit
2.0341 of 5 stars
1.05.00.00.03.50.82.5
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
3.8341 of 5 stars
2.33.00.04.12.74.20.6
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.6443 of 5 stars
2.82.00.00.02.81.70.6
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
1.8044 of 5 stars
3.53.00.00.01.41.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enhabit, Inc. stock logo
EHAB
Enhabit
2.00
Hold$8.50-16.80% Downside
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
2.50
Moderate Buy$24.0018.17% Upside
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.50
Reduce$5.0027.23% Upside
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
3.00
Buy$7.00131.79% Upside

Current Analyst Ratings Breakdown

Latest TOI, FLGT, INNV, and EHAB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$7.00
5/6/2025
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$16.00 ➝ $23.00
5/5/2025
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$24.00 ➝ $25.00
3/6/2025
Enhabit, Inc. stock logo
EHAB
Enhabit
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/4/2025
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$22.00 ➝ $16.00
(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.50$3.14 per share3.25$13.90 per share0.73
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$292.45M2.11$3.97 per share5.12$38.24 per share0.53
InnovAge Holding Corp. stock logo
INNV
InnovAge
$831.68M0.64N/AN/A$1.90 per share2.07
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$403.15M0.57N/AN/A$0.77 per share3.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enhabit, Inc. stock logo
EHAB
Enhabit
-$80.50M-$2.77N/A35.23N/A-11.24%1.67%0.80%8/5/2025 (Estimated)
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$167.82M-$1.33N/AN/AN/A-59.39%-1.81%-1.66%8/1/2025 (Estimated)
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$21.34M-$0.23N/A65.50N/A-3.19%-9.45%-4.84%N/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$83.07M-$0.70N/AN/A-17.63%-186.83%-34.58%8/11/2025 (Estimated)

Latest TOI, FLGT, INNV, and EHAB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/A-$0.18N/A-$0.21N/A$104.41 million
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
5/6/2025Q3 2025
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 million
5/2/2025Q1 2025
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$0.18$0.04+$0.22-$0.37$71.26 million$73.46 million
3/24/2025Q4 2024
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enhabit, Inc. stock logo
EHAB
Enhabit
0.85
1.46
1.46
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/A
4.41
4.41
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.27
1.16
1.16
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
5.91
2.49
2.27

Institutional Ownership

CompanyInstitutional Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
48.06%
InnovAge Holding Corp. stock logo
INNV
InnovAge
12.26%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%

Insider Ownership

CompanyInsider Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
1.90%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
31.76%
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.40%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
8.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,90050.64 million49.33 millionOptionable
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
1,01030.44 million20.87 millionOptionable
InnovAge Holding Corp. stock logo
INNV
InnovAge
2,000135.01 million133.35 millionOptionable
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
66075.56 million68.38 millionNot Optionable

Recent News About These Companies

Q1 2025 Oncology Institute Inc Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enhabit stock logo

Enhabit NYSE:EHAB

$10.22 -0.04 (-0.43%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$10.22 0.00 (-0.01%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Fulgent Genetics stock logo

Fulgent Genetics NASDAQ:FLGT

$20.31 -0.21 (-1.02%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$20.14 -0.17 (-0.84%)
As of 05/23/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

InnovAge stock logo

InnovAge NASDAQ:INNV

$3.93 -0.09 (-2.24%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$3.93 0.00 (0.00%)
As of 05/23/2025 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOI

$3.02 +0.03 (+1.00%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$3.00 -0.02 (-0.66%)
As of 05/23/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.